alexa Postoperative racing performance in standardbreds and thoroughbreds with osteochondrosis of the tarsocrural joint: 109 cases (1984-1990).
Genetics & Molecular Biology

Genetics & Molecular Biology

Journal of Molecular Biomarkers & Diagnosis

Author(s): Beard WL, Bramlage LR, Schneider RK, Embertson RM

Abstract Share this page

Abstract Medical records for 64 Thoroughbred and 45 Standardbred horses with osteochondrosis dissecans (OCD) of the tarsocrural joint that were treated by means of arthroscopic removal of the fragments before 2 years of age and before beginning racing were reviewed. Lesion site was recorded for all horses. The other foals from the dams of these surgically treated horses (siblings) were identified from mare progeny records. Racing data, including number of starts and money won during the 2- and 3-year-old racing years were obtained from the Jockey Club and the United States Trotting Association for affected horses and their siblings. Statistical analysis was performed to test the hypothesis that there was no difference between the racing performance of horses with OCD of the tarsocrural joint that were surgically treated by means of arthroscopic removal of the fragments prior to racing and that of their siblings. One hundred and seventy-four lesions were recorded in 109 horses. The distribution of lesions was similar to that previously reported. For the Standardbreds, 22\% of those that had surgery raced as 2 year olds and 43\% raced as 3 year olds, compared with 42 and 50\% of the siblings that raced as 2 year olds and 3 year olds, respectively. For the Thoroughbreds, 43\% of those that had surgery raced as 2 year olds and 78\% raced as 3 year olds, compared with 48\% and 73\% of the siblings that raced as 2 year olds and 3 year olds, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
This article was published in J Am Vet Med Assoc and referenced in Journal of Molecular Biomarkers & Diagnosis

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 9th International Conference and Expo on Molecular & Cancer Biomarkers
    August 23-24, 2017 Birmingham, UK
  • 2nd International Conference on Medical Imaging and Diagnosis
    London, UK
  • 22nd International Conference on Cancer Drugs and Therapeutics
    Paris, France
  • International Conference on Oncology Nursing and Cancer Care
    Singapore City, Singapore
  • World Summit on Cell Signalling and Cancer Therapy
    Toronto, Canada
  • International Conference on Radiology and Imaging
    New York, USA

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords